Rugby: Moana Pasifika owners confident they can continue to bankroll team
Moana Pasifika celebrate beating the Blues during the recent Super Rugby season.
Photo:
Andrew Cornaga/www.photosport.nz
The owners of the Moana Pasifika Super Rugby side are confident they can continue to bankroll the team, despite the loss of lucrative government contracts.
Pasifika Medical Association Group (PMA) - which bought the franchise last year - is next month set to lose contracts with Whānau Ora through its entity Pasifika Futures.
PMA has held the contracts for the past 10 years, but a shake-up of government funding has led to the change.
The
New Zealand Herald
reported
PMA's contracts for community health services were worth nearly $45 million, making up over half the organisation's revenue.
According to the
Herald
, over the past few years PMA has used the Whānau Ora contract to bolster Moana Pasifika's finances to the tune of $770,000 a year.
However PMA chair Dr Kiki Maoate maintained their "financial position is on track to finish the year ahead of forecast".
In a statement, he said "every dollar invested into Moana Pasifika is an investment in the future of Pasifika youth and their families"..
"From the beginning, Pasifika Medical Association and Pasifika Futures have supported the establishment of Moana Pasifika, including through our Whānau Ora commissioning where contract outcomes and purpose were aligned… and has been delivered with transparency and care for community outcomes."
Dr Kiki Maoate
Photo:
Pasifika Medical Association Group
Moana Pasifika joined the Super Rugby competition in 2022, and this year enjoyed the best results of their four-year tenure,
finishing seventh
.
Maoate said the organisation was reviewing "all funding priorities in line with changing circumstances".
"Moana Pasifika is more than a Super Rugby club. It's a celebration of who we are and what we can become. Sport has long been a wave that carries Pasifika people forward into education, enterprise, leadership and community service.
"As both a team and a movement, Moana Pasifika exists to lift up our people and strengthen our communities."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
2 hours ago
- RNZ News
Woman had to beg to pay hefty Watercare bill in instalments after issue with faulty smart meter
The faulty meters means some customers had been getting zero use bills for months. Photo: Nunnicha Supagrit A Watercare customer says she had to beg to pay off a huge catch-up bill in instalments after a faulty smart meter gave her zero-use bills for months. The issue stemmed from Watercare's smart meters, which it told Checkpoint more than 13,000 of were not working . The water supplier had known about problems with one type of smart meter since October last year, and the fault had so far affected about one third of the 40,000 meters installed since 2022. Hamideh, from West Auckland's Henderson, told Checkpoint, she had complained to Watercare more than once about an issue with her smart meter which began in November last year, but while waiting for the issue to be fixed she was sent a bill to the amount of $219. "It was shocking - I was not prepared for it." She had lost her job a few months ago and knew she wouldn't be able to afford to pay off the bill in one go. "I called Watercare and asked to pay in instalments and they said no, not possible. I explained I lost my job and was told that I should have saved for it." After about 25 minutes on the phone, Hamideh said it was accepted she could pay in instalments. "But there's still no reading on my water meter. I was quite pissed off when she told me I had to save for it. "They told me the meter just stopped syncing data... they didn't communicate the problem with their customers. It's been seven months and no solution." Watercare chief financial officer Angela Neeson told Checkpoint she was really sorry to hear about Hamideh's experience and said it needed resolving. "That it's taken seven months to resolve does sound unusual." Neeson said when Watercare realised there was an issue with the smart meters processes were put in place to identify when the meters started to become faulty. "The process does take a couple of months because the first month of a zero read could just be someone on holiday or out of the house but after the second month we move the customer to a manual read," she said. She acknowledged there was nothing on the Watercare website about the faulty meters and said Watercare had "been focused on liasing with the customers". "We watch for month two to identify when there is potentially a faulty meter." Watercare had now stopped installing that particular meter, Neeson confirmed but she did not give a timeline on how long it would take to replace the faulty ones. "We will always look and how we can do better and we're considering whether we don't wait that one month after a zero read to investigate so that it shortens that period for customers. "We are always looking at how we can do things better". Neeson confirmed water bills would increase 7.2 percent at the start of July which she said reflected the cost of running the operations and becoming financially independent. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
3 hours ago
- RNZ News
Melatonin, ADHD medication and magic mushrooms - what are NZ's new changes in access to them?
Access to melatonin, psilocybin and ADHD treatment is changing. Photo: AFP / File / RNZ illustration Explainer - The government has changed regulations on several medications in the past fortnight. Here's what you need to know about melatonin, ADHD medicine and medicinal psilocybin access. Melatonin, which is used to treat sleeping problems, has up until now been tightly restricted in New Zealand, unlike many other countries. But it will soon be available over the counter at pharmacies, Associate Health Minister David Seymour said last week . It will be available in pharmacies as pills up to 5mg in packs with up to 10 days' supply, or pills up to 3mg. "Modified release doses" - pills, capsules, gels and medical devices which allow the drug to be administered over a specific period - could also be available with dosages of up to 2mg. Melatonin will remain prescription-only for children and adolescents , "following expert clinical advice to ensure proper oversight when used by younger patients," Seymour said. Melatonin is used to treat sleep disorders. Photo: Quin Tauetau/RNZ Melatonin is a hormone made by the pineal gland in your brain that helps regulate sleep cycles. It tends to decrease as we get older. Supplements are taken to help those with insomnia or other sleeping problems. "Most countries in the world allow you to buy it," Seymour said, noting Kiwis would often buy it on trips overseas and take it back home despite it being restricted here. "That makes no sense." One Auckland mother told RNZ recently that melatonin was "life saving" and a "game-changer" for her 10-year-old son with autism. Still, not everyone is convinced that it works. Studies have so far shown melatonin to be a "dud" in terms of effectiveness, Dr David Reith, an associate professor of pharmacology at the University of Otago, told RNZ last year. "The studies indicate it gets you to sleep 15 minutes quicker. But not that it keeps you asleep, improves the quality of your sleep, or increases the amount of time you sleep." Watch: David Seymour on changes to melatonin and psilocybin access It will take a little more time to see it on your chemist's shelf. Seymour said he called on the melatonin manufacturers of the world "to apply to bring their products into our country." "We are entirely dependent on the manufacturers to apply to have specific products available in New Zealand. The market dried up because it was so restricted nobody wanted to sell here. "But when we did this with pseudoephedrine it was a matter of months before the products were on the shelves and I hope we can beat that record." GPs and nurse practitioners will soon be able to diagnose and prescribe medications for attention-deficit hyperactivity disorder, or ADHD, to adults age 18 and over. The changes affect the stimulant medicines methylphenidate, dexamfetamine and lisdexamfetamine, also sold under various brand names. Medsafe and Pharmac announced the changes on Tuesday . Until now, it has required a written recommendation from a psychiatrist or paediatrician to start prescribing ADHD medications, a process which can take months. "I have heard stories of many people with ADHD who have been unable to get a diagnosis and treatment in a timely manner because of long wait items and costs associated with seeing a specialist," Mental Health Minister Matt Doocey said in announcing the change . Children and teenagers 17 and younger will be able to get prescriptions from nurse practitioners who work in mental health services as well as psychiatrists and paediatricians. Dr Anna Skinner, the Chief Clinical Advisor for Primary Care at Health New Zealand, told Checkpoint that the change would help eliminate barriers for people to get treatment. "People have been accessing private psychiatry at considerable personal costs," she said. Ritalin is one of several drugs that treat ADHD. Photo: CC 2.0 Health agencies have set the start date at 1 February 2026 to address potential supply issues related to methylphenidate or Ritalin, and to give more time for workforce preparation. However, not all GPs and nurse practitioners will be equipped to carry out the work immediately, so it will be important to talk to your physician about your options, Pharmac said. The assessments will not be done in your typical 15-minute GP visit and will possibly require multiple visits to specialised staff, Skinner said. "It's certainly not a 15-minute diagnosis so it's not something that everybody will be able to access the morning after the changes." In making the announcement Doocey said it was important to have consistency as the policy changes. "The Ministry of Health is working with sector representatives to develop a clinical principles framework for the assessment and treatment of ADHD. This will ensure there is quality and consistency for supporting patients with ADHD in New Zealand." Psilocybin, a chemical from certain mushrooms, has been used to treat depression. Photo: Pixabay Psilocybin is a chemical obtained from certain kinds of mushrooms. It's been used in spiritual rituals, recreationally and as medicine over the years - and picked up the tag "magic mushrooms". It's also become a possible treatment for depression, as psilocybin is believed to interact with serotonin receptors in the brain. Serotonin is a neurotransmitter which regulates mood and other bodily functions and is sometimes called "the happiness chemical". It will still be an unapproved medicine but available for clinical treatment for the first time outside of trials. "Psilocybin is a medicine that can treat untreatable depression," Seymour said in making the announcement. "It was first researched in the 1950s and '60s and more recently there's been extensive research and approvals by the FDA in the United States to be able to use these types of medicines." Australia made a similar move to allow prescriptions of it in clinical settings two years ago. However, initially its use will be very limited in New Zealand. Only one person at the moment in all of New Zealand - psychiatrist Dr Cameron Lacey, based in Christchurch. Speaking to RNZ recently he said it had taken "a long time, a lot of energy and perseverance" to get to the approval stage, which had taken around four years. The treatment isn't cheap in other countries, however - Dr Lacey said it could run from NZ$16,500 to NZ$40,000 for the course of psychotherapy and psilocybin sessions. He hoped it would be cheaper when it comes to New Zealand. "I'm hopeful we can work with Health New Zealand to create a funding pathway for those who have failed to respond to current standard treatments and endure significant symptoms to be able to get access to this treatment." The latest data from the New Zealand Drug Foundation shows the use of psychedelics - which includes substances such as LSD, psilocybin and ketamine - has doubled in the past six years. Dr Lacey will operate under strict reporting and record-keeping requirements, Seymour said. He hoped more psychiatrists would apply to use it. "If a doctor believes psilocybin can help, they should have the tools to try." Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
4 hours ago
- RNZ News
Music licenser chasing up hundreds of businesses for playing music in the workplace
All commercial businesses, including offices and trade sites, are required to pay a licencing fee, with any music played for non-personal use. (File photo) Photo: Eric Nopanen / Unsplash A music licensing organisation is chasing up hundreds of businesses a week asking them to pay-up for the tunes they are using, so that artists get what they are owed. OneMusic licences certain music for use in commerical settings like pubs, club, offices, hairdressers, gym and factories, nearly anything outside of personal use. Charges vary, playing the radio in a factory with 72 workers would cost $49 a month for licence, a gym with 500 members would pay about $104 dollars a month. OneMusic Director, Greer Davies told Checkpoint music licencing had been around for a while, and the company saw a huge lack of awareness from businesses. "It comes down to a lack of education and so our team are continually contacting businesses to educate them about the use of music and their legal requirements for music creators." "OneMusic's been around for 13 years but music licencing existed prior to that as well, and it's an it's an education that we need to take people on." Davies said they were speaking to hundreds of different businesses a week, aiming to educate them about the licencing programme. One of those business owners was a Hawkes Bay florist who told Checkpoint she was called by OneMusic to see if she was paying licence fees , which she wasn't. Francie Croy said she listened to the radio on her phone out the back of her Waipukurau shop, but the music licensing organisation told her she must buy a licence or turn the music off. "No one out front of the shop can hear it, but she said to me that I would still have a licence to have to do that because sometimes Newstalk ZB plays music." She said after the phone call she was sent another email from OneMusic. "It was a certificate thing, saying this is confirmation that you have advised us that you do not play music in your business and will not play music represented by this place. "It includes television, radio stations, apps, digital music services, Spotify, Apple, YouTube, CD's, DVD's, Blu-ray, vinyl and cassette tapes, and the list goes on." Croy said she had no idea that being charged for playing music at her business was even a possibility. All commercial businesses, including offices and trade sites, were required to pay the licencing fee, with any music played for non-personal use. Although the licence covered a large variety of circumstances, Davies said they had a specific focus on a group of businesses. "Our current focus is educating business owners across hospitality, retail, service providers and exercise." Croy said she was shocked by the request from OneMusic, which a few other businesses in the area also received. She said it seemed unlikely that someone from OneMusic had visited her small store in Waipukurau, and thought they must be sending random emails. Davies said the company had representatives visiting shops to vet whether they were playing music unlicensed. "These representatives carry out a range of tasks for us, some verifying music that's being played and identified the source of that music. They also check new businesses that may have opened in vacant locations that we've been unable to reach." She said the fees from the licence go towards artists to ensure they are paid for their music and OneMusic was partnered with APRA AMCOS and Recorded Music NZ, who pass the costs onto the artists. "Each of those organisations distribute the revenue that OneMusic earns on their behalf, but about 85 cents every dollar is distributed." Davies said for those that fail to pay for a licence there could be consequences, often resulting in fines. "Generally a business owner will understand the legal obligation and obtain the relevant licence, but reluctantly, if they don't, we will pursue and potentially end up in court." "The most recent court cases were in 2018 and 2019, and the damages were around about $15,000, $18,000." The Ministry of Business Innovation and Employment said OneMusic licensed copyright works and MBIE did not have oversight of the scheme. It said businesses that play music for their staff and/or customers need a licence and the licensing fees paid are distributed to producers and recording artists. "If a business does not wish to pay any licensing fee to play music, they should not play music. To do so without a licence means the copyright owner may sue the business and award damages. "A business who wishes to dispute the terms and conditions of the scheme may make an application to the Copyright Tribunal. If the Tribunal determines that the licensing scheme is unfair it may order changes," it said. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
